ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala +1 more
wiley +1 more source
ESC Heart Failure, EarlyView.The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner +15 more
wiley +1 more source
Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. [PDF]
Front Endocrinol (Lausanne), 2023 García E +13 more
europepmc +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Inter‐atrial shunt device therapy has shown mixed results in clinical trials, with clinical ‘non‐responders’ typically showing features of more advanced heart failure. We aimed to analyse the haemodynamic and clinical response of a novel left atrial to coronary sinus (LA‐CS) shunt device in patients with higher natriuretic peptide (NP ...
Ryan J. Tedford +9 more
wiley +1 more source
Effect of adrenaline on serum mid-regional pro-atrial natriuretic peptide and central blood volume. [PDF]
Exp Physiol, 2022 Sejersen C +5 more
europepmc +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Early diuresis and natriuresis are commonly used to assess the efficacy of decongestive therapy following an acute heart failure episode. There is limited knowledge regarding which parameter better predicts adverse clinical outcomes, especially in the outpatient setting.
M. Cobo Marcos +15 more
wiley +1 more source
Retracted: The Clinical Efficacy of Cedilanid and Isosorbide Dinitrate plus Pericardial Dissection for Chronic Constrictive Pericarditis in the Elderly and Its Influence on Plasma Endothelin, Atrial Natriuretic Peptide, and Systemic Immune-Inflammation Index. [PDF]
Evid Based Complement Alternat Med, 2023 And Alternative Medicine EC.
europepmc +1 more source
Signs of congestion, quality of life and short‐term rehospitalization in patients with heart failure
ESC Heart Failure, EarlyView.Abstract Aims Signs of congestion are a treatment target in patients with heart failure (HF), as they affect patients' well‐being, and congestion scores are associated with the risk of early readmission. However, which individual sign of congestion has the strongest association with quality of life (QoL) and HF rehospitalization remains uncertain ...
Geert H.D. Voordes +4 more
wiley +1 more source
Effectiveness of Atrial Natriuretic Peptide in the Treatment of Critically Ill Patients: A Systematic Review and Meta-Analysis. [PDF]
J Clin MedOdutola PO, Olarewaju A, Shah P.
europepmc +1 more source
The Correlations of Human Atrial Natriuretic Peptide on Cardiac Function and Hemodynamics in Pediatric Septic Shock. [PDF]
Open Access Emerg Med, 2022 Setyaningtyas A +3 more
europepmc +1 more source